No spam - just the good stuff

Subscribe to our newsletter

News

Innovation

New study reveals how neurons die in Alzheimer’s disease

Leveraging the past to illuminate longevity for the future

Will psychedelics produce the next longevity drug?

Dr Halland Chen on longevity medicine, mindset and the potential of psychedelics to improve human longevity.

First-ever clinical trial of ketone supplementation to treat and prevent frailty

Synthego and bit.bio join forces on genetic engineering platform for cell therapy

Dynamic models of complete, day 14 human embryos grown from stem cells

Elastin Biosciences announces breakthrough discovery in elastin restoration

Clock.bio launches to decode rejuvenation biology across human genome

Naked mole rat ‘longevity gene’ extends lifespan in mice

Inflammaging discovery could slow aging and prevent age-related diseases

New research ties obesity to sex- and age-specific genes

Protein-targeting vaccine signposts Alzheimer’s breakthrough

Eight longevity habits that could lengthen your life by 20 years

Impact of epigenetic mechanisms on age-related diseases

Dunedin Study receives £1.4m award to explore midlife aging

‘Pitstop’ cell protein discovery points to healthier aging

Integrated Biosciences announces drug discovery platform

Alzheimer’s drug donanemab Phase 3 data announced

Altered gut bacteria could be early warning sign of Alzheimer’s

Mitochondrial DNA fragments in blood shown to be important biomarkers for aging

Researchers develop compound that prevents free radical production in mitochondria

Could regenerating the thymus boost human longevity?

FDA approves novel Alzheimer’s treatment

Corpse-spotting: Why seeing the dead could be bad for your health

Researchers uncover new RNA-guided genome editing system

New regenerative stem cell therapy for heart disease shows promise

Cambrian Bio launches Telos Biotech to enable more robust cell therapies

Zombie upside – senescent cells aid regeneration in salamanders

New ‘meta-cell’ developed in the fight against Alzheimer’s

Introducing Chinmo – The Youth Gene

Study shows exercise can ‘fight off’ diabetes risk

Protein IL-17 found to play a key role in skin aging

Find us here ...

Subscribe to our newsletter

© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.